Healthcare provider profile · identity verified

Greg M Blakely, MD

Allopathic & Osteopathic Physicians|Internal Medicine · PINEHURST, NC · NPI 1962442723

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Greg M Blakely, MD received $64.26 in general payments during 2025 across 3 reported records.

Boston Scientific Corporation accounted for 44.8% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 226 claims for Eliquis by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Paxlovid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$64.26

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boston Scientific Corporation	Unresolved — no canonical attribution shown	$28.77	44.8%	1	2025
PFIZER INC.	Unresolved — no canonical attribution shown	$21.42	33.3%	1	2025
InSightec,Inc	Unresolved — no canonical attribution shown	$14.07	21.9%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$64.26	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
WATCHMAN Access System Normalized: watchman access system	Device	Boston Scientific Corporation	$28.77	1	2025
Source payment records 2025-10-24 · Boston Scientific Corporation · $28.77 · Open Payments source
ELIQUIS Normalized: eliquis	Drug	PFIZER INC.	$21.42	1	2025
Source payment records 2025-09-26 · PFIZER INC. · $21.42 · Open Payments source
NURTEC ODT Normalized: nurtec odt	Drug	PFIZER INC.	$21.42	1	2025
Source payment records 2025-09-26 · PFIZER INC. · $21.42 · Open Payments source
Exablate Normalized: exablate	Device	InSightec,Inc	$14.07	1	2025
Source payment records 2025-02-13 · InSightec,Inc · $14.07 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
ELIQUIS eliquis	2025	Eliquis	2024	226	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
PFIZER INC. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063	Eliquis · 2024 Exact normalized brand match · 1 Part D row	226	45
PFIZER INC. Exact reporting entity; no affiliate inference	2025	PAXLOVID open payments reported associated product	CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432	Paxlovid · 2024 Exact normalized brand match · 1 Part D row	14	14

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1224	314
Amlodipine Besylate	Amlodipine Besylate	1072	283
Lisinopril	Lisinopril	873	233
Hydrochlorothiazide	Hydrochlorothiazide	766	209
Omeprazole	Omeprazole	662	164
Levothyroxine Sodium	Levothyroxine Sodium	463	108
Rosuvastatin Calcium	Rosuvastatin Calcium	457	124
Metoprolol Succinate	Metoprolol Succinate	440	111
Losartan Potassium	Losartan Potassium	418	112
Metformin Hcl	Metformin Hcl	411	101
Gabapentin	Gabapentin	392	107
Tamsulosin Hcl	Tamsulosin Hcl	391	107
Pravastatin Sodium	Pravastatin Sodium	280	71
Pantoprazole Sodium	Pantoprazole Sodium	256	77
Trazodone Hcl	Trazodone Hcl	245	58
Simvastatin	Simvastatin	241	69
Potassium Chloride	Potassium Chloride	228	56
Eliquis	Apixaban	226	45
Allopurinol	Allopurinol	223	54
Mirtazapine	Mirtazapine	220	42
Fluticasone Propionate	Fluticasone Propionate	207	83
Tramadol Hcl	Tramadol Hcl	206	38
Jardiance	Empagliflozin	194	45
Glimepiride	Glimepiride	187	56
Escitalopram Oxalate	Escitalopram Oxalate	184	47
Valsartan	Valsartan	180	47
Atenolol	Atenolol	171	42
Carvedilol	Carvedilol	169	49
Alprazolam	Alprazolam	168	30
Spironolactone	Spironolactone	146	37
Furosemide	Furosemide	145	55
Montelukast Sodium	Montelukast Sodium	145	40
Doxazosin Mesylate	Doxazosin Mesylate	144	37
Duloxetine Hcl	Duloxetine Hcl	137	27
Ezetimibe	Ezetimibe	135	37
Prednisone	Prednisone	133	103
Zolpidem Tartrate	Zolpidem Tartrate	133	20
Metoprolol Tartrate	Metoprolol Tartrate	132	38
Xarelto	Rivaroxaban	123	24
Sertraline Hcl	Sertraline Hcl	119	27
Paroxetine Hcl	Paroxetine Hcl	114	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	113	31
Meloxicam	Meloxicam	113	38
Fluoxetine Hcl	Fluoxetine Hcl	109	23
Ozempic	Semaglutide	107	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	106	25
Clonazepam	Clonazepam	102	23
Glipizide	Glipizide	101	21
Finasteride	Finasteride	99	28
Clopidogrel	Clopidogrel Bisulfate	96	30
Alendronate Sodium	Alendronate Sodium	95	30
Donepezil Hcl	Donepezil Hcl	84	23
Pregabalin	Pregabalin	81	17
Pioglitazone Hcl	Pioglitazone Hcl	79	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	76	15
Warfarin Sodium	Warfarin Sodium	75	20
Albuterol Sulfate Hfa	Albuterol Sulfate	70	29
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	69	18
Benazepril Hcl	Benazepril Hcl	68	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	19
Januvia	Sitagliptin Phosphate	66	11
Lovastatin	Lovastatin	65	14
Telmisartan	Telmisartan	65	15
Methocarbamol	Methocarbamol	63	23
Ramipril	Ramipril	63	15
Famotidine	Famotidine	61	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	suppressed
Valacyclovir	Valacyclovir Hcl	59	16
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	58	13
Hydralazine Hcl	Hydralazine Hcl	58	15
Synthroid	Levothyroxine Sodium	58	12
Metformin Hcl Er	Metformin Hcl	54	17
Irbesartan	Irbesartan	53	12
Mounjaro	Tirzepatide	53	11
Celecoxib	Celecoxib	52	16
Buspirone Hcl	Buspirone Hcl	51	suppressed
Bupropion Xl	Bupropion Hcl	50	11
Ipratropium Bromide	Ipratropium Bromide	50	22
Venlafaxine Hcl Er	Venlafaxine Hcl	50	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	47	suppressed
Clonidine Hcl	Clonidine Hcl	46	11
Dutasteride	Dutasteride	44	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	43	12
Terazosin Hcl	Terazosin Hcl	43	suppressed
Colchicine	Colchicine	42	14
Esomeprazole Magnesium	Esomeprazole Magnesium	42	11
Doxycycline Hyclate	Doxycycline Hyclate	41	31
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	41	12
Citalopram Hbr	Citalopram Hydrobromide	40	12
Diazepam	Diazepam	40	11
Olmesartan Medoxomil	Olmesartan Medoxomil	40	12
Lorazepam	Lorazepam	38	suppressed
Fenofibrate	Fenofibrate	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	13
Ondansetron Hcl	Ondansetron Hcl	37	12
Rybelsus	Semaglutide	37	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	30
Memantine Hcl	Memantine Hcl	35	suppressed
Dilt-Xr	Diltiazem Hcl	34	suppressed
Myrbetriq	Mirabegron	33	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	15
Lansoprazole	Lansoprazole	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	29
Torsemide	Torsemide	29	11
Propranolol Hcl	Propranolol Hcl	28	suppressed
Propranolol Hcl Er	Propranolol Hcl	28	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	28	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Galantamine Er	Galantamine Hbr	26	suppressed
Nitroglycerin	Nitroglycerin	26	15
Nystatin	Nystatin	25	17
Triamcinolone Acetonide	Triamcinolone Acetonide	24	21
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	23	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Febuxostat	Febuxostat	21	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	21	suppressed
Aliskiren	Aliskiren Hemifumarate	20	suppressed
Baclofen	Baclofen	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Temazepam	Temazepam	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	17
Ondansetron Odt	Ondansetron	18	14
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Carisoprodol	Carisoprodol	17	suppressed
Cilostazol	Cilostazol	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	17	suppressed
Amoxicillin	Amoxicillin	16	11
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Cephalexin	Cephalexin	15	11
Levemir Flexpen	Insulin Detemir	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Cefdinir	Cefdinir	14	14
Entresto	Sacubitril/Valsartan	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Acarbose	Acarbose	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Armour Thyroid	Thyroid,pork	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Multaq	Dronedarone Hcl	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Tiadylt Er	Diltiazem Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$64.26 · 3 records	Boston Scientific Corporation	ELIQUIS, Exablate, NURTEC ODT, WATCHMAN Access System	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Eliquis play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error